The Company is a biopharmaceutical company that has established a diverse drug development platform to actualize therapeutics indicated for the treatment of cancer and neuropathic pain.
Monoclonal Antibody Therapeutics
The company is a specialty biopharmaceutical company that utilizes an immunology-based drug development platform to actualize therapeutics indicated for cancer and autoimmune disease. The company’s …
Prostate Cancer, Ultrasound Thermal Therapy
The company is a medical devices company that has developed a novel therapeutic technology for the treatment of prostate cancer. The company’s apparatus uses non-invasive MRI imaging to identify prostate cell masses, and a trans-urethral ultrasound applicator …
NCTR – July 27th, 2010
The latest issue of the New Companies & Technologies Report (NCTR) has been published on innovative companies and technologies in health and medicine. * If you are not a subscriber to the […]
New Imaging Technique May Provide a Closer Look at Cell Death
The information could allow researchers to observe cellular changes as a patient undergoes cancer treatment, and could aid in the development of new molecular therapeutics for diseases such as cancer.
Nektar Announces Positive Data on Ovarian Cancer Drug
An experimental drug from Nektar Therapeutics was able to shrink tumors and reduce a cancer biomarker in women with advanced ovarian cancer in a mid-stage study.
Celiac Disease: A Significant, Unmet Clinical Need
A disease that affects a significant number of Americans, that requires extensive and often frustrating lifestyle modifications, and that has no approved pharmaceutical treatment: It’s an enticing opportunity for drug companies.
OneMedForum New York 2010: Key Days for Innovation in Healthcare
Though selected in order to give a platform to lesser recognized businesses, the companies presenting demonstrated the vast diversity of the healthcare and life science spaces.
